Literature DB >> 1699146

Cerebral microthrombosis in symptomatic cerebral vasospasm--a quantitative histological study in autopsy cases.

S Suzuki1, M Kimura, M Souma, H Ohkima, T Shimizu, T Iwabuchi.   

Abstract

A comparative investigation of the pathogenetic factor in symptomatic cerebral vasospasm was made by quantitative histological and clinical studies in four patients who died immediately of symptomatic cerebral vasospasm (Cases 1-4) and in two who died without fatal cerebral vasospasm (Cases 5 and 6). Histological examination of the brain from Cases 1 and 2 found many white and fibrin microthrombi together with ischemic and infarctic changes in the territories of spastic arteries, which corresponded to the low-density areas (LDAs) observed on computed tomographic (CT) scans and the typical neurological symptoms. In Case 3, who had suffered severe vasospasms in bilateral anterior cerebral and middle cerebral arteries, bilateral LDAs were observed on CT scans and multiple fibrin thrombi were seen diffusely throughout the brain. In Case 4, extensive bilateral LDAs (lt greater than rt) were observed on CT scans, and multiple microthrombi were seen diffusely but predominantly in the left cerebral hemisphere. Only in Case 3 the possible complication of disseminated intravascular coagulation could not be ruled out. Only negligible thrombi were observed in Cases 5 and 6, whose immediate cause of death was considered to be acute hydrocephalus and aneurysmal rerupture, respectively. Distributions of microthrombi were significantly greater in the regions clinically identified to have been ischemic or infarctic.

Entities:  

Mesh:

Year:  1990        PMID: 1699146     DOI: 10.2176/nmc.30.309

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  35 in total

1.  Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.

Authors:  Jared M Pisapia; Xiangsheng Xu; Jane Kelly; Jamie Yeung; Geneive Carrion; Huaiyu Tong; Sudha Meghan; Omar M El-Falaky; M Sean Grady; Douglas H Smith; Sergei Zaitsev; Vladimir R Muzykantov; Michael F Stiefel; Sherman C Stein
Journal:  Exp Neurol       Date:  2011-11-04       Impact factor: 5.330

2.  The Role of Platelet Activation and Inflammation in Early Brain Injury Following Subarachnoid Hemorrhage.

Authors:  Jennifer A Frontera; J Javier Provencio; Fatima A Sehba; Thomas M McIntyre; Amy S Nowacki; Errol Gordon; Jonathan M Weimer; Louis Aledort
Journal:  Neurocrit Care       Date:  2017-02       Impact factor: 3.210

3.  Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage.

Authors:  Y Hirashima; S Nakamura; S Endo; N Kuwayama; Y Naruse; A Takaku
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

4.  The Role of Oxidative Stress in Microvascular Disturbances after Experimental Subarachnoid Hemorrhage.

Authors:  Toshio Fumoto; Masato Naraoka; Takeshi Katagai; Yuchen Li; Norihito Shimamura; Hiroki Ohkuma
Journal:  Transl Stroke Res       Date:  2019-01-09       Impact factor: 6.829

Review 5.  An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage.

Authors:  Jasper H van Lieshout; Maxine Dibué-Adjei; Jan F Cornelius; Philipp J Slotty; Toni Schneider; Tanja Restin; Hieronymus D Boogaarts; Hans-Jakob Steiger; Athanasios K Petridis; Marcel A Kamp
Journal:  Neurosurg Rev       Date:  2017-02-18       Impact factor: 3.042

Review 6.  Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.

Authors:  Daniel Naranjo; Michal Arkuszewski; Wojciech Rudzinski; Elias R Melhem; Jaroslaw Krejza
Journal:  Neuroradiol J       Date:  2013-12-18

Review 7.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

Review 8.  Cerebral vasospasm: a consideration of the various cellular mechanisms involved in the pathophysiology.

Authors:  Jacob Hansen-Schwartz
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

9.  Controversy: does prevention of vasospasm in subarachnoid hemorrhage improve clinical outcome?

Authors:  Michael N Diringer
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

10.  Changes of plasma thromboxane level in subarachnoid haemorrhage. A study with 11-dehydro-TXB2 as measuring index.

Authors:  S Suzuki; Y Nonogaki; K Ebina; T Sekiya; T Iwabuchi; M Takiguchi
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.